Correlation Between 4D Molecular and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on 4D Molecular and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Apellis Pharmaceuticals.
Diversification Opportunities for 4D Molecular and Apellis Pharmaceuticals
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between FDMT and Apellis is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of 4D Molecular i.e., 4D Molecular and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between 4D Molecular and Apellis Pharmaceuticals
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Apellis Pharmaceuticals. In addition to that, 4D Molecular is 1.32 times more volatile than Apellis Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 6,266 in Apellis Pharmaceuticals on November 1, 2024 and sell it today you would lose (3,227) from holding Apellis Pharmaceuticals or give up 51.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Apellis Pharmaceuticals |
4D Molecular and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Apellis Pharmaceuticals
The main advantage of trading using opposite 4D Molecular and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |